Toxicity and Healthcare Utilisation of Dose-dense Chemotherapy for Early Breast Cancer
Purpose: Clinical trials provide evidence that dose-dense chemotherapy (ddC) is more efficacious than standard chemotherapy schedules in the treatment of early breast cancer (EBC). The impact on toxicity and healthcare utilisation remains uncertain in real-world populations. The aim of this retrospective adjusted cohort comparison was to measure the impact following adoption of ddC.
Source: Clinical Oncology - Category: Radiology Authors: B. Langley, M. Brennan, D. Cameron, L. Hayward, P.S. Hall Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Radiology | Toxicology